Jazz Pharmaceuticals plc Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax
Jazz Pharmaceuticals plc (JAZZ) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax of $212.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax · last filed 2018-02-27
- Jazz Pharmaceuticals plc other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2017 was $212.00K.
- Jazz Pharmaceuticals plc other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2016 was $0.00.
- Jazz Pharmaceuticals plc other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2015 was $0.00.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 12 month |
|---|---|
| 2017-12-31 | $212.00K 10-K · filed 2018-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |